Tuberculosis vaccines: beyond bacille Calmette-GuerinImmune response to mycobacterial infection: lessons from flow cytometryESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the questionDefensins: The Case for Their Use against Mycobacterial InfectionsMycobacterial endocarditis: a comprehensive reviewThree-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteriaMycobacterial aerosols and respiratory disease.Mycobacterium haemophilum osteomyelitis: case report and review of the literature.Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapyProgressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener's), complicated by hearing loss requiring cochlear implantationMycobacterium and the coat of many lipids.Mycobacterium riyadhense infections.Mycobacterium lentiflavum infection in immunocompetent patientMycoketide: a CD1c-presented antigen with important implications in mycobacterial infectionMycobacterium triplex pulmonary disease in immunocompetent host.Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis.Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature.Pattern recognition: recent insights from Dectin-1The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.Innate immune effectors in mycobacterial infection.Mycobacterium bovis-induced Aneurysm after Intravesical Bacillus Calmette-Guérin Therapy: A Case Study and Literature Review.Human genetics of mycobacterial diseaseIRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary ImmunodeficienciesPhase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary DiseaseInterleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial InfectionsMulticenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis PatientsPhase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsPilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis
P921
Q1017169-28a91be4-4e0d-ef44-fbf1-ee29dbf6443bQ11663754-FE0C14A3-A668-4F43-9AD0-D89876958AFFQ12204-17146ca6-498d-5600-1ee9-f75efa5f2da3Q1420459-11dfecf1-406e-4000-bac8-172ef6420650Q36956-0af3472d-4859-61d3-e292-a234640d759aQ4782756-b7ef41e4-4f6a-baf5-fbb0-6d4948f3f68fQ55787425-3fc2a5c1-4af0-bfe3-9a92-c176aabdfba3Q618032-2409C74B-2C15-4D65-A20A-C6C39CFD2174Q6946984-22a49fb7-4ca8-8073-ab88-3396363b38cbQ707388-8cb2dddf-443a-1402-0ab2-02bcb9b91192
P279
Q22242669-CCE60575-3C93-4491-AA21-A0866604E58EQ27002561-1E0B31E9-1465-47D4-AD35-E461EAD491FFQ27011691-F998CDBC-4821-47D2-B8FB-8D164561CA1BQ28067137-0973EEC6-8C1B-40EE-AC6B-0A58D9CE0AD7Q28080539-34FA64A9-9282-4849-AF57-83B64F9EEEF5Q28658279-DE9830A5-158F-412D-BE3C-C71D47AA7CDBQ30815192-2B4B24A2-56D0-4D98-944D-2F4122FDFFA7Q33239515-5073A2DB-EDD7-453D-A7AB-214932A6341FQ33332129-479655d9-427d-2fea-93fa-e577be37007eQ33570595-8de55728-4b58-c090-9734-783016c5f50cQ33644586-8B0D3B9A-027E-49D4-994B-B8C7DC163FB8Q33836681-6DABA71F-771F-4326-A3B1-1A63A7358327Q34402665-368A8D7B-67A8-4890-9D7D-33A963157982Q34766315-5B308084-6348-49D7-909C-454FF3BDD838Q35621751-2B89A625-8D4F-4ACE-9BC2-B4F3EACA960AQ35804276-2A2D95DC-C02F-44BE-AD42-BB445A6BB003Q35868335-EA94ED2D-AFB6-41CD-95A2-F1A2731433D3Q35880761-0627E8C6-0DEE-4E1D-BAEB-6363263EAD5FQ36205953-796FA9AF-F08D-4F48-A125-C3CF07E2E229Q37109619-F6314FDE-0EA8-4294-9B24-6BDDCCF5D564Q37395165-96473117-3BC3-446B-B0BF-75EFA7DDBB14Q37773161-970A5544-C07A-41E6-9D05-796A91142AD9Q37832959-F5DC4C0B-4FC3-446D-901C-41FF83123AF3Q47726120-14C9EA91-D3FE-4F7C-BD65-E179307187EBQ58772716-50387DE8-DA44-4DBB-8D10-0CC11A4C09F1Q60916292-193BB2A0-91DD-44B3-B877-4F9BE96395A8Q64807517-262382C8-D899-469C-A4BA-C9F1EDD94192Q66060911-94C23D70-735D-4528-BE00-A3F7126D8E4DQ66062096-47E3E4B0-246E-45EC-9E35-03FC1E42D61EQ66062113-EE87F02F-4DD1-44AC-81DB-A7A2A913B5F9Q66067501-3C30889B-C692-4C8D-9D77-971EFDD78BB3
P921
description
choroba zakaźna
@pl
human disease
@en
مرض يصيب الإنسان
@ar
ମାନବ ରୋଗ
@or
name
Mykobakterioza
@pl
infecció micobacteriana
@ca
infección micobacteriana
@es
infection à mycobacterium
@fr
mycobacterium infectious disease
@en
mykobakterieinfeksjon
@nn
mykobakteriell infektionssjukdom
@sv
Микобактериоз
@ru
միկոբակտերիոզ
@hy
ମାଇକୋବ୍ୟାକ୍ଟେରିମ ସଂକ୍ରାମକ ରୋଗ
@or
type
label
Mykobakterioza
@pl
infecció micobacteriana
@ca
infección micobacteriana
@es
infection à mycobacterium
@fr
mycobacterium infectious disease
@en
mykobakterieinfeksjon
@nn
mykobakteriell infektionssjukdom
@sv
Микобактериоз
@ru
միկոբակտերիոզ
@hy
ମାଇକୋବ୍ୟାକ୍ଟେରିମ ସଂକ୍ରାମକ ରୋଗ
@or
altLabel
Infection due to mycobacteria
@en
Mycobacterial Infection
@en
Mycobacterial disease NOS (disorder)
@en
Mycobacterial disease
@en
Mycobacterium infection, unspecified (disorder)
@en
Mycobacterium infectious disease
@en
Mykobakteriozy
@pl
Unspecified disease due to mycobacteria
@en
enfermedad infecciosa miobacteriana
@es
gruźlica
@pl
prefLabel
Mykobakterioza
@pl
infecció micobacteriana
@ca
infección micobacteriana
@es
infection à mycobacterium
@fr
mycobacterium infectious disease
@en
mykobakterieinfeksjon
@nn
mykobakteriell infektionssjukdom
@sv
Микобактериоз
@ru
միկոբակտերիոզ
@hy
ମାଇକୋବ୍ୟାକ୍ଟେରିମ ସଂକ୍ରାମକ ରୋଗ
@or
P486
P1748
P1995
P2176
P2888
P2892
P31
P486
P5082
mykobakterieinfeksjon
P672
C01.252.410.040.552